Oxford Pharmaceuticals is in the process of setting up A state-of-the-art Sterile Pharmaceutical Manufacturing facility in mainland Dubai, to produce high-in-demand, Parental Dosage forms (Injectable products) in Glass Ampules and Vials. The company aims to start to the 1st phase of production by 2025 and aims to expand to Biosimilar products in phase 2 and Oncology block in phase 3.